Shanghai Argo Biopharmaceutical CO LTD
-
Argo Biopharma Completed RMB 300 million in Series A+ financing led by SDIC Investment
Nov,2023. Shanghai Argo Biopharmaceutical Co., LTD. (hereinafter referred to as Argo Biopharma) Completed RMB 300 million in Series A+ financing led by SDIC Investment.